These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27116766)

  • 21. Eliminating waste in US health care.
    Berwick DM; Hackbarth AD
    JAMA; 2012 Apr; 307(14):1513-6. PubMed ID: 22419800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healthcare reform: administrative rulemaking. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-29. PubMed ID: 23297441
    [No Abstract]   [Full Text] [Related]  

  • 23. The health of healthcare, Part II: patient healthcare has cancer.
    Waldman D
    J Med Pract Manage; 2013; 29(2):113-6. PubMed ID: 24236323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceuticals and medical devices: Medicare Part D.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-31. PubMed ID: 25771554
    [No Abstract]   [Full Text] [Related]  

  • 25. Insurance connection.
    Pa Dent J (Harrisb); 2013; 80(2):15-7. PubMed ID: 23729089
    [No Abstract]   [Full Text] [Related]  

  • 26. A review of data on the U.S. health sector: fall 2004.
    Hellander I
    Int J Health Serv; 2005; 35(2):265-89. PubMed ID: 15932007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accountable care organizations: the case for flexible partnerships between health plans and providers.
    Goldsmith J
    Health Aff (Millwood); 2011 Jan; 30(1):32-40. PubMed ID: 21209435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Top 10 business issues you'll face in 2013.
    Verdon DH; Bowers LA; Bendix J; Zimlich R; Sofranec D
    Med Econ; 2013 Jan; 90(1):12-6, 19. PubMed ID: 23898587
    [No Abstract]   [Full Text] [Related]  

  • 29. Pricing in the Market for Anticancer Drugs.
    Howard DH; Bach PB; Berndt ER; Conti RM
    J Econ Perspect; 2015; 29(1):139-62. PubMed ID: 28441702
    [No Abstract]   [Full Text] [Related]  

  • 30. Exchange perspective: hospitals encourage designs reducing negative effects.
    Daly R
    Mod Healthc; 2012 Mar; 42(10):12-3. PubMed ID: 22462088
    [No Abstract]   [Full Text] [Related]  

  • 31. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.
    Daniel GW; Malone DC
    J Manag Care Pharm; 2007 Mar; 13(2):142-54. PubMed ID: 17330975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AIDS patients in Louisiana may lose insurance over anti-kickback laws.
    Carlson J
    Mod Healthc; 2014 Feb; 44(8):10. PubMed ID: 24730148
    [No Abstract]   [Full Text] [Related]  

  • 33. Branded prescription drug fee. Final regulations, temporary regulations, and removal of temporary regulations.
    Internal Revenue Service (IRS), Treasury
    Fed Regist; 2014 Jul; 79(144):43631-45. PubMed ID: 25118373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicare and the affordable care act.
    Moon M
    J Aging Soc Policy; 2012; 24(2):233-47. PubMed ID: 22497361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceuticals and Medical Devices: Business Practices.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-38. PubMed ID: 29361660
    [No Abstract]   [Full Text] [Related]  

  • 36. National health spending in 2011: overall growth remains low, but some payers and services show signs of acceleration.
    Hartman M; Martin AB; Benson J; Catlin A;
    Health Aff (Millwood); 2013 Jan; 32(1):87-99. PubMed ID: 23297275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare reform: administrative rulemaking.
    Berry MD
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-51. PubMed ID: 25775706
    [No Abstract]   [Full Text] [Related]  

  • 38. Control of fraud and abuse in Medicare and Medicaid.
    Pies HE
    Am J Law Med; 1977; 3(3):323-32. PubMed ID: 415602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No credit due: lower spending increases are rooted in a bad economy.
    Raske K; Vladeck B
    Mod Healthc; 2012 Mar; 42(13):26. PubMed ID: 22533260
    [No Abstract]   [Full Text] [Related]  

  • 40. Bending the cost curve through market-based incentives.
    Antos JR; Pauly MV; Wilensky GR
    N Engl J Med; 2012 Sep; 367(10):954-8. PubMed ID: 22852881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.